TLY-012

DB18336ExperimentalProtein Based Therapies

TLY-012 is a PEGylated recombinant human tumor necrosis factor-related apoptosis-inducing ligand (PEGylated TRAIL).

Mechanism: Pharmacologically active on Tumor necrosis factor receptor superfamily member 10B and Tumor necrosis factor receptor superfamily member 10A
Curator reviewed
Code names: TLY 012

Resolves to

Compound

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with TLY-012, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.